Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33190187.
- Also identified by DOI 10.1007/s00223-020-00777-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The key players of the chronic kidney disease-mineral and bone disorders (CKD-MBD) are calcium, phosphate, PTH, FGF23, and the vitamin D hormonal system. The progressive reduction of kidney function greatly modifies the tightly interrelated mechanisms that control these parameters. As a result, important changes occur in the bone and mineral hormonal axis, leading to changes in bone turnover with relevant consequences in clinical outcomes, such as decrease in bone mass with increased bone fragility and bone fractures and increased vascular and valvular calcification, also with great impact in the cardiovascular outcomes. So far, the knowledge of the mineral and bone disorders in CKD and the increased variety of efficacious therapies should lead to a better prevention and management of CKD-MBD.
Medical subject headings
- Chronic Kidney Disease-Mineral and Bone Disorder
- Renal Insufficiency, Chronic